- Sales of Co.'s Qsymia have already been hurt since the launch in December.
- Co. has asked the FDA to expand distribution to a number of retail pharmacies and expects a decision by April.
Reaction details (15:13)
- No immediate reaction to the news, last trade at USD 12.96 (-3.35%)
02 Jan 2013 - 15:12 - Equities - Source: B4THESTREET.COM
RANsquawk provides audio news and commentary for over 15,000 professional traders and brokers worldwide. Services include: